FR2380299A1 - Hypoglycaemic glucoside cpds. of gallic and ellagic acid - prepd. from pomegranate roots or from glucose and gallic acid chloride - Google Patents

Hypoglycaemic glucoside cpds. of gallic and ellagic acid - prepd. from pomegranate roots or from glucose and gallic acid chloride

Info

Publication number
FR2380299A1
FR2380299A1 FR7703610A FR7703610A FR2380299A1 FR 2380299 A1 FR2380299 A1 FR 2380299A1 FR 7703610 A FR7703610 A FR 7703610A FR 7703610 A FR7703610 A FR 7703610A FR 2380299 A1 FR2380299 A1 FR 2380299A1
Authority
FR
France
Prior art keywords
gallic
roots
glucose
pomegranate
prepd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7703610A
Other languages
French (fr)
Inventor
Gilbert Carraz
Jacques Willemot
Pierre Demenge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7703610A priority Critical patent/FR2380299A1/en
Publication of FR2380299A1 publication Critical patent/FR2380299A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Glucosides (I) of gallic acid and ellagic acid, are new. The cpds. are hypoglycemics. A mixture of various glucosides may be isolated by solid/liquid extn. of the roots of pomegranate, Punica granatum var Albescens, or if the roots are first debarked, from the red flowered variety of Punica granatum. The extn. may be effected using a lower alkanol or a mixture of acetone and dilute HCl. Penta-O-galloyl-beta-glucose (specifically claimed) may be prepd. by reaction of a gallic acid derivative having protected hydroxyl groups with beta-D-glucose, followed by removal of the protecting groups.
FR7703610A 1977-02-09 1977-02-09 Hypoglycaemic glucoside cpds. of gallic and ellagic acid - prepd. from pomegranate roots or from glucose and gallic acid chloride Withdrawn FR2380299A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7703610A FR2380299A1 (en) 1977-02-09 1977-02-09 Hypoglycaemic glucoside cpds. of gallic and ellagic acid - prepd. from pomegranate roots or from glucose and gallic acid chloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7703610A FR2380299A1 (en) 1977-02-09 1977-02-09 Hypoglycaemic glucoside cpds. of gallic and ellagic acid - prepd. from pomegranate roots or from glucose and gallic acid chloride

Publications (1)

Publication Number Publication Date
FR2380299A1 true FR2380299A1 (en) 1978-09-08

Family

ID=9186509

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7703610A Withdrawn FR2380299A1 (en) 1977-02-09 1977-02-09 Hypoglycaemic glucoside cpds. of gallic and ellagic acid - prepd. from pomegranate roots or from glucose and gallic acid chloride

Country Status (1)

Country Link
FR (1) FR2380299A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2695390A1 (en) * 1992-09-09 1994-03-11 Ir2M Organometallic derivatives resulting from the complexation of tannins or mixtures of tannins with metals having an oxidation degree of at least 3 and a pharmaceutical composition containing them.
US6387418B1 (en) * 1999-04-19 2002-05-14 Stewart And Lynda Resnick Revocable Trust Pomegranate extracts and methods of using thereof
WO2004009094A1 (en) * 2002-07-24 2004-01-29 Ohio University Methods and compositions for treating diabetes mellitis
US7727563B2 (en) 1999-04-19 2010-06-01 Pom Wonderful, Llc Methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans
US8372454B2 (en) 1999-04-19 2013-02-12 Pom Wonderful Llc Methods of making pomegranate compounds for the treatment of erectile dysfunction

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2695390A1 (en) * 1992-09-09 1994-03-11 Ir2M Organometallic derivatives resulting from the complexation of tannins or mixtures of tannins with metals having an oxidation degree of at least 3 and a pharmaceutical composition containing them.
WO1994006809A2 (en) * 1992-09-09 1994-03-31 I.R.2.M. Pharmaceutical compositions containing associations of metals and tannins or tannin mixtures
WO1994006809A3 (en) * 1992-09-09 1994-04-28 I R 2 M Pharmaceutical compositions containing associations of metals and tannins or tannin mixtures
US6387418B1 (en) * 1999-04-19 2002-05-14 Stewart And Lynda Resnick Revocable Trust Pomegranate extracts and methods of using thereof
US7727563B2 (en) 1999-04-19 2010-06-01 Pom Wonderful, Llc Methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans
US8372454B2 (en) 1999-04-19 2013-02-12 Pom Wonderful Llc Methods of making pomegranate compounds for the treatment of erectile dysfunction
US8734868B1 (en) 1999-04-19 2014-05-27 Pom Wonderful, Llc Methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans
WO2004009094A1 (en) * 2002-07-24 2004-01-29 Ohio University Methods and compositions for treating diabetes mellitis

Similar Documents

Publication Publication Date Title
ATE62249T1 (en) HOMODISACCHARID HYPOGLYCEMIC AGENT.
Yamaguchi et al. The Completed Sequence of a Glycopeptide Obtained from Taka-amylase A
SE399276B (en) WAY TO PREPARE THE COATING WITH SOLVENT-FREE POLYISOCYANATE, BLOCKED WITH (CYCLO-) ALKANOL, AND HYDROXYL GROUP CONTAINING COMPOUNDS AND SUITABLE COATING AGENT
JPS5390368A (en) Preparation of cation-modified cellulose derivative
IE39856L (en) Aminosugars
SE9301677L (en) synthesis Method
MY103912A (en) Adriamycin
JPS568320A (en) Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent
AU469963B2 (en) Treatment of cellulosic matter with activated nitrogen or other activated gases
FR2380299A1 (en) Hypoglycaemic glucoside cpds. of gallic and ellagic acid - prepd. from pomegranate roots or from glucose and gallic acid chloride
IL56345A (en) Pharmaceutical compositions containing sterol glycosides or spiroketal steroid glycosides with activity as prostaglandinsynthetase inhibitors
JPS6461459A (en) Moranoline derivative
DE3675977D1 (en) PHARMACEUTICAL COMPOSITIONS FOR REDUCING THE SIDE EFFECTS OF ANTI-CANCER CHEMOTHERAPY AND INCREASING IMMUNITY.
IE35215L (en) Polynucleotides.
AU507674B2 (en) Compounding pharmaceuticals which are difficult to absorb into bloodstream
JPS5432493A (en) Preparation of macrolide antibiotics derivatives
IE37351L (en) Saccharase inhibitor.
JPS5414513A (en) Novel composition
FR2219950A1 (en) Stabilized enzymes and proteins - linked chemically to a vinylene carbonate polymer through the O, N- or S-atoms of the protein
ES8704934A1 (en) A novel substance having anti-tumor activity, a microbiological process for the preparation thereof and its use as a medicament.
Zemlyakov et al. Synthesis of β-glycosides of n-acetylglucosamine in the presence of HgI 2
SU644686A2 (en) Arrangement for one-by-one delivery of logs
AU485489B2 (en) 1, 5(6)-DISUBSTITUTED BENZIMIDAZOLE-2 CARBAMATE DERIVATIVES HAVING ANTHELMINTIC activity
JPS5435280A (en) Preparation of yeast cells
Yaguchi et al. Ion-exchange chromatography of 2-amino-2, 6-dideoxyhexoses and of the methyl ethers of 2-amino-2, 6-dideoxy-D-glucopyranose (quinovosamine) and 2-amino-2, 6-dideoxy-D-galactopyranose (fucosamine)

Legal Events

Date Code Title Description
ST Notification of lapse